Propofol for office oral and maxillofacial anesthesia: the case against low-dose ketamine.
Casagrande
Angelle M
AM
Division of Oral and Maxillofacial Surgery, School of Dentistry, University of the Pacific, Oakland, CA, USA. acasagrande@sazoms.com
D000556:Ambulatory Surgical Procedures; D000762:Anesthesia Recovery Period; D000766:Anesthesia, Dental / Q000009:adverse effects / Q000379:methods*; D000778:Anesthetics, Dissociative / Q000008:administration & dosage / Q000009:adverse effects*; D018686:Anesthetics, Intravenous / Q000008:administration & dosage* / Q000009:adverse effects; D003693:Delirium / Q000139:chemically induced; D006212:Hallucinations / Q000139:chemically induced; D006801:Humans; D007649:Ketamine / Q000008:administration & dosage / Q000009:adverse effects*; D015742:Propofol / Q000008:administration & dosage* / Q000009:adverse effects; D012131:Respiratory Insufficiency / Q000139:chemically induced; D012798:Sialorrhea / Q000139:chemically induced
D000778:Anesthetics, Dissociative; D018686:Anesthetics, Intravenous; D007649:Ketamine; D015742:Propofol